Intestinal ion secretion pathways

Intestinal ion secretion pathways represent a complex network of channels, transporters, and signaling molecules that regulate the movement of electrolytes and water across the intestinal epithelium [2, 19]. The primary driver of secretion is the active transport of chloride (Cl-) and bicarbonate (HCO3-) through the apical membrane via the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Calcium-activated chloride channels (CaCC), which creates an osmotic gradient for water to follow into the lumen [6, 14, 18]. This process is balanced by basolateral transporters like the Na-K-2Cl cotransporter (NKCC1) and is regulated by secondary messengers such as cAMP and cGMP [9, 17]. Dysregulation of these pathways leads to significant pathology: hyperactivation by bacterial toxins (e.g., cholera) causes life-threatening secretory diarrhea, while hypoactivation or genetic defects (e.g., cystic fibrosis) can cause severe constipation or obstruction [11, 20]. Modern therapeutics modulate these pathways to treat functional gastrointestinal disorders, with drugs like linaclotide and lubiprostone serving to increase fluid secretion in cases of chronic constipation [10, 17].

Other names

Intestinal electrolyte secretionIntestinal fluid secretionEnterocyte ion transport pathwaysSecretory diarrheal pathways

Drugs targeting these pathways act as Guanylate cyclase C (GC-C) agonists, Chloride channel 2 (ClC-2) activators, Sodium-hydrogen exchanger 3 (NHE3) inhibitors, or inhibitors of apical chloride channels such as CFTR and CaCC [6, 11, 14, 17].